UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

Gene therapy, 2000-05, Vol.7 (10), p.867-874

2000

Volltextzugriff (PDF)

Analysis of genetically engineered oncolytic herpes simplex viruses in human prostate cancer organotypic cultures

Gene therapy, 2009-12, Vol.16 (12), p.1477-1482

2009

Volltextzugriff (PDF)

Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect

Gene therapy, 2009-07, Vol.16 (7), p.905-915

2009

Volltextzugriff (PDF)

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells

Neuro-oncology (Charlottesville, Va.), 2012-02, Vol.14 (2), p.132-144

2012

Volltextzugriff (PDF)

Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers

Cancer gene therapy, 2006-03, Vol.13 (3), p.253-265

2006

Volltextzugriff (PDF)

Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells

Cancer gene therapy, 2009-07, Vol.16 (7), p.551-560

2009

Volltextzugriff (PDF)

Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207

Human gene therapy, 1999-09, Vol.10 (13), p.2237-2243

1999

Volltextzugriff (PDF)

Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models

Cancer gene therapy, 2013-01, Vol.20 (1), p.17-24

2013

Volltextzugriff (PDF)

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

Gene therapy, 1999-04, Vol.6 (4), p.564-572

1999

Volltextzugriff (PDF)

Treatment of breast cancer stem cells with oncolytic herpes simplex virus

Cancer gene therapy, 2012-10, Vol.19 (10), p.707-714

2012

Volltextzugriff (PDF)

Oncolytic herpes simplex virus vectors for cancer virotherapy

Cancer gene therapy, 2002-12, Vol.9 (12), p.967-978

2002

Volltextzugriff (PDF)

Oncolytic Herpes Simplex Virus Vector with Enhanced MHC Class I Presentation and Tumor Cell Killing

Proceedings of the National Academy of Sciences - PNAS, 2001-05, Vol.98 (11), p.6396-6401

2001

Volltextzugriff (PDF)

Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1

Cancer research (Chicago, Ill.), 1995-11, Vol.55 (21), p.4752-4756

1995

Volltextzugriff (PDF)

Transcriptional targeting of herpes simplex virus for cell-specific replication

Journal of Virology, 1997-07, Vol.71 (7), p.5124-5132

1997

Volltextzugriff (PDF)

Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy

Human gene therapy, 1999-11, Vol.10 (17), p.2869-2878

1999

Volltextzugriff (PDF)

Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide

Molecular pharmacology, 1996-08, Vol.50 (2), p.236

1996

Volltextzugriff (PDF)

Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas

Nature medicine, 1995-09, Vol.1 (9), p.938-943

1995

Volltextzugriff (PDF)

Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity

Human gene therapy, 1999-02, Vol.10 (3), p.385-393

1999

Volltextzugriff (PDF)

Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation of Intracerebral Injection in Nonhuman Primates

Journal of Virology, 1999-08, Vol.73 (8), p.6319-6326

1999

Volltextzugriff (PDF)

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1

Human gene therapy, 1998-10, Vol.9 (15), p.2177-2185

1998

Volltextzugriff (PDF)

Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant

Cancer research (Chicago, Ill.), 1994-08, Vol.54 (15), p.3963-3966

1994

Volltextzugriff (PDF)

Oncolytic viruses and their application to cancer immunotherapy

Cancer immunology research, 2014-04, Vol.2 (4), p.295-300

2014

Volltextzugriff (PDF)

Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats

Journal of neuro-oncology, 1994-01, Vol.19 (2), p.137-147

1994

Volltextzugriff (PDF)

Ionizing Radiation Does Not Alter the Antitumor Activity of Herpes Simplex Virus Vector G207 in Subcutaneous Tumor Models of Human and Murine Prostate Cancer

Neoplasia (New York, N.Y.), 2001, Vol.3 (5), p.451-456

2001

Volltextzugriff (PDF)

Sites of Termination of in vitro DNA Synthesis on Ultraviolet- and N-acetylaminofluorene-treated φ X174 Templates by Prokaryotic and Eukaryotic DNA Polymerases

Proceedings of the National Academy of Sciences - PNAS, 1981-01, Vol.78 (1), p.110-114

1981

Volltextzugriff (PDF)

1 – 25 von 399

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(368)
Mit Volltextzugriff
(253)

Publikationsform

Artikel
(399)

Sprache

Englisch
(374)
Russisch
(25)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

Analysis of genetically engineered oncolytic herpes simplex viruses in human prostate cancer organotypic cultures

Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells

Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers

Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells

Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207

Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

Treatment of breast cancer stem cells with oncolytic herpes simplex virus

Oncolytic herpes simplex virus vectors for cancer virotherapy

Oncolytic Herpes Simplex Virus Vector with Enhanced MHC Class I Presentation and Tumor Cell Killing

Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1

Transcriptional targeting of herpes simplex virus for cell-specific replication

Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy

Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide

Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas

Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity

Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation of Intracerebral Injection in Nonhuman Primates

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1

Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant

Oncolytic viruses and their application to cancer immunotherapy

Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats

Ionizing Radiation Does Not Alter the Antitumor Activity of Herpes Simplex Virus Vector G207 in Subcutaneous Tumor Models of Human and Murine Prostate Cancer

Sites of Termination of in vitro DNA Synthesis on Ultraviolet- and N-acetylaminofluorene-treated φ X174 Templates by Prokaryotic and Eukaryotic DNA Polymerases

Aktive Filter

Suchergebnisse filtern